We are live on ! Find out more
MGNX icon

MacroGenics

128 hedge funds and large institutions have $68.3M invested in MacroGenics in 2025 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 36 increasing their positions, 42 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 128128 (0)

0% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 18

4.14% less ownership

Funds ownership: 89.45%85.32% (-4.1%)

14% less repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 42

61% less call options, than puts

Call options by funds: $75K | Put options by funds: $191K

63% less capital invested

Capital invested by funds: $182M → $68.3M (-$114M)

Holders
128
Holders Change
Holders Change %
0%
% of All Funds
1.72%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
18
Increased
36
Reduced
42
Closed
18
Calls
$75K
Puts
$191K
Net Calls
-$116K
Net Calls Change
+$354K
Name Holding Trade Value Shares
Change
Change in
Stake
BG
1
Bellevue Group
Switzerland
$12.6M
AC
2
Armistice Capital
New York
$8M +$52.2K +20,000 +0.3%
BlackRock
3
BlackRock
New York
$6.24M -$376K -144,047 -3%
Vanguard Group
4
Vanguard Group
Pennsylvania
$5.62M +$286K +109,311 +3%
WA
5
Wasatch Advisors
Utah
$4.13M -$622K -238,245 -7%
FLSM
6
Frazier Life Sciences Management
California
$4.03M
Acadian Asset Management
7
Acadian Asset Management
Massachusetts
$2.92M +$2.66M +1,017,726 +79%
Millennium Management
8
Millennium Management
New York
$2.19M -$2.98M -1,140,471 -40%
Geode Capital Management
9
Geode Capital Management
Massachusetts
$1.85M +$60K +22,971 +2%
State Street
10
State Street
Massachusetts
$1.79M -$139K -53,220 -4%
Renaissance Technologies
11
Renaissance Technologies
New York
$1.46M +$1.6M +613,747 +114%
RSCM
12
Rock Springs Capital Management
Maryland
$1.45M +$239K +91,567 +9%
Two Sigma Advisers
13
Two Sigma Advisers
New York
$1.36M -$132K -50,400 -5%
Connor, Clark & Lunn Investment Management (CC&L)
14
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$1.04M +$186K +71,152 +10%
JP Morgan Chase
15
JP Morgan Chase
New York
$946K +$518K +198,255 +36%
Jacobs Levy Equity Management
16
Jacobs Levy Equity Management
New Jersey
$845K +$260K +99,447 +18%
Two Sigma Investments
17
Two Sigma Investments
New York
$832K -$538K -205,847 -24%
Dimensional Fund Advisors
18
Dimensional Fund Advisors
Texas
$820K -$187K -71,663 -10%
Charles Schwab
19
Charles Schwab
California
$667K -$4.31K -1,650 -0.3%
Northern Trust
20
Northern Trust
Illinois
$662K -$51.5K -19,701 -4%
PA
21
Pinnacle Associates
New York
$605K -$66.2K -25,354 -5%
GCP
22
GSA Capital Partners
United Kingdom
$570K +$527K +201,926 +82%
Macquarie Group
23
Macquarie Group
Australia
$533K
Morgan Stanley
24
Morgan Stanley
New York
$434K -$1.99M -762,941 -69%
Marshall Wace
25
Marshall Wace
United Kingdom
$380K -$247K -94,738 -24%

MGNX Hedge Fund Activity: Q1 2025 in Review

128 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in MacroGenics (MGNX) for Q1 2025, worth a combined $68.3M — down 63% from $182M a quarter earlier.

Fund positioning in MGNX was balanced in Q1 2025: 18 funds opened new positions, 18 closed out, 36 added to existing stakes and 42 trimmed.

The largest buyer was Acadian Asset Management, adding an estimated $2.66M. The largest seller was Millennium Management, cutting an estimated $2.98M.

  • 128 institutional investors held MacroGenics (MGNX) as of Q1 2025, unchanged from Q4 2024.
  • Funds reported $68.3M of MacroGenics stock for Q1 2025, down 63% quarter-over-quarter.
  • 18 funds opened new MacroGenics positions in Q1 2025 and 18 closed out, a net change of 0 holders.
  • The largest MacroGenics buyer in Q1 2025 was Acadian Asset Management, an estimated $2.66M added.
  • The largest MacroGenics seller in Q1 2025 was Millennium Management, an estimated $2.98M sold.

Based on aggregated 13F filings for Q1 2025.